KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Receivables: 2009-2024

Historic Change in Receivables for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $216.0 million.

  • Bausch Health Companies' Change in Receivables rose 1047.83% to $218.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $303.0 million, marking a year-over-year increase of 131.30%. This contributed to the annual value of $216.0 million for FY2024, which is 10.77% up from last year.
  • Bausch Health Companies' Change in Receivables amounted to $216.0 million in FY2024, which was up 10.77% from $195.0 million recorded in FY2023.
  • Bausch Health Companies' 5-year Change in Receivables high stood at $229.0 million for FY2021, and its period low was -$170.0 million during FY2020.
  • In the last 3 years, Bausch Health Companies' Change in Receivables had a median value of $195.0 million in 2023 and averaged $156.0 million.
  • Per our database at Business Quant, Bausch Health Companies' Change in Receivables tumbled by 335.90% in 2020 and then surged by 242.11% in 2023.
  • Yearly analysis of 5 years shows Bausch Health Companies' Change in Receivables stood at -$170.0 million in 2020, then spiked by 234.71% to $229.0 million in 2021, then tumbled by 75.11% to $57.0 million in 2022, then soared by 242.11% to $195.0 million in 2023, then rose by 10.77% to $216.0 million in 2024.